Clinical Trials Directory

Trials / Completed

CompletedNCT05403801

STAMP+CBT mHealth for Cancer Pain

Harnessing Mobile Technology to Deliver Tailored, Brief Pain-CBT for Advanced Cancer Patients on Opioids for Pain

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test whether a mobile application developed to help people with cancer pain is useful and helpful to patients with cancer.

Detailed description

This research study involves the use of a smartphone app at home in addition to surveys and potentially an interview at the end of the study. The research study procedures include screening for eligibility, study interventions include surveys at the beginning of the study, after 4 weeks, and after 6 weeks and use of the smartphone app. Participants will be on this research study for up to 6 weeks. It is expected that about 15 people will take part in this research study This research study is a Feasibility Study, which is the first-time investigators are examining this mobile application meant to help participant to learn behavioral techniques to manage cancer pain. The purpose is to make sure the app is usable and helpful for patients with cancer, and to get feedback about patient experiences after using the app for four weeks.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSTAMP+CBT applicationUse the STAMP+CBT mobile app for 4 weeks (intervention period, 4 weeks for content introduction, extended 2 weeks for review of content if patient's request this

Timeline

Start date
2022-07-01
Primary completion
2023-06-08
Completion
2023-06-27
First posted
2022-06-03
Last updated
2025-01-01
Results posted
2025-01-01

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05403801. Inclusion in this directory is not an endorsement.